CAH Stock Analysis: Buy, Sell, or Hold?
CAH - Cardinal Health, Inc.
$214.88
3.65 (1.73%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 05, 2026
4d
Get Alerted When CAH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CAH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CAH shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$340.73
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$211.56
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CAH is currently trading at $214.88, which is considered extended relative to its 30-day fair value range of $204.84 to $211.84. The stock's valuation (Forward PE: 18.8) is in line with its historical norms (20.4). Remarkably, the market is currently pricing in an annual earnings decline of 2.8% over the next few years. This pessimistic expectation contrasts with the company's recent 10.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CAH is in a strong uptrend. The price is approaching resistance at $216.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $232.80 (+10.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CAH is in a strong uptrend. The price is approaching resistance at $216.51. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $232.80 (+10.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$204.84 -
$211.84
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
48.6%
Protect Your Profits
Holding CAH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($232.80)
Fair Price Analysis
30-Day Fair Range
$204.84 -
$211.84
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$206.27
Resistance Level
$216.51
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
18.76
Wall Street Target
$232.80
(+10.2%)
Revenue Growth (YoY)
22.4%
Earnings Growth (YoY)
10.6%
Profit Margin
0.7%
Valuation Discount vs History
-2.8% cheaper
PE vs Historical
18.8 vs 20.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.8%
(market-implied from PE analysis)
1-Year Target
$205.32
(-3%)
2-Year Target
$199.57
(-6%)
3-Year Target
$193.98
(-8%)
3-Yr Target (if PE normalizes)
(PE: 19→20)
$210.91
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 12.5%)
$357.88
(+69%)
Base:
(SPY PE: 18.8, Growth: 12.5%)
$301.11
(+43%)
Bear:
(PE: 15.9, Growth: 12.5%)
$255.94
(+21%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 31.73 | Current EPS (TTM): $6.63
Bull Case
$392.99
(+83%)
Analyst growth 69.8%, PE expands to 34.9
Base Case
$357.26
(+66%)
Market implied 69.8%, PE stable at 31.7
Bear Case
$143.07
(-33%)
Severe decline -20.0%, PE contracts to 27.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.8 to 20.4
Stabilization Target:
$229.67
(+8.7%)
PE Expansion Potential:
+8.7%
Last updated: January 31, 2026 2:46 AM ET
Data refreshes hourly during market hours. Next update: 3:46 AM
Data refreshes hourly during market hours. Next update: 3:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CAH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2025-09-05
Jason M Hollar
SELL
35901 shares
2025-08-20
Jason M Hollar
SELL
107705 shares
2025-08-19
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$942 | 60 HOLD |
|
COR
Cencora Inc. |
BUY
17 analysts |
$397 | 65 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$78 | 50 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 54 HOLD |
|
OMI
Owens & Minor Inc |
HOLD
6 analysts |
$6 | 53 HOLD |
Advanced CAH Option Strategies
Professional options setups generated by AI based on today's CAH price and gamma walls.
